海利生物:控股子公司三类医疗器械注册申请获受理

同花顺财经
Sep 10
海利生物公告,控股子公司陕西瑞盛生物科技有限公司于近日收到国家药品监督管理局下发的医疗器械注册申请受理通知。该医疗器械为天然骨修复材料,适用于颌骨缺损修复。受理号为CQZ2501670,产品类别为第三类医疗器械。目前注册申请已获得受理,后续需经过审评审批、制证等流程。该产品为Ⅲ类医疗器械,获批上市后将在口腔骨缺损修复领域丰富瑞盛生物的产品线。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10